$HALB
Halberd Corp

2022 Q3 Form 10-Q Financial Statement

#000147793222006489 Filed on August 29, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $1.217K
YoY Change 6.38%
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $1.217K
YoY Change -231.71%
Gross Profit Margin 100.0%
Selling, General & Admin $20.93K
YoY Change -5.47%
% of Gross Profit 1720.13%
Research & Development $203.4K
YoY Change 1.88%
% of Gross Profit 16713.89%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $296.9K
YoY Change 30.59%
Operating Profit -$295.6K
YoY Change 29.53%
Interest Expense $1.538K
YoY Change 9.86%
% of Operating Profit
Other Income/Expense, Net -$1.538K
YoY Change 9.86%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$297.2K
YoY Change 29.41%
Net Earnings / Revenue -24418.41%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 515.9M shares 512.9M shares
Diluted Shares Outstanding 512.9M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $5.410K
Receivables
Other Receivables
Total Short-Term Assets $13.57K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $4.819K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.819K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $13.57K
Total Long-Term Assets $4.819K
Total Assets $18.39K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $267.8K
YoY Change
Accrued Expenses $9.717K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $484.5K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $484.5K
Total Long-Term Liabilities
Total Liabilities $634.5K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$6.185M
YoY Change
Common Stock $51.37K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$616.1K -$624.0K
YoY Change
Total Liabilities & Shareholders Equity $18.39K
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$297.2K
YoY Change 29.41%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
16133
dei Entity Central Index Key
EntityCentralIndexKey
0001458631
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
511621968 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-04-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-8731
dei Entity Registrant Name
EntityRegistrantName
HALBERD CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3538414
dei Entity Address Address Line1
EntityAddressAddressLine1
P.O. Box 25
dei Entity Address City Or Town
EntityAddressCityOrTown
Jackson Center
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei City Area Code
CityAreaCode
814
dei Local Phone Number
LocalPhoneNumber
786-8849
dei Security12b Title
Security12bTitle
Common
dei Trading Symbol
TradingSymbol
HALB
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
515874842 shares
CY2022Q2 us-gaap Cash
Cash
8162 usd
CY2021Q3 us-gaap Cash
Cash
40321 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5410 usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21750 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
13572 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
62071 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4819 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1281 usd
CY2022Q2 us-gaap Assets
Assets
18391 usd
CY2021Q3 us-gaap Assets
Assets
63352 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
267813 usd
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
177010 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9717 usd
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5300 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
206934 usd
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
216400 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
484464 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
398710 usd
CY2022Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
150000 usd
CY2021Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
150000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
634464 usd
CY2021Q3 us-gaap Liabilities
Liabilities
548710 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
513650338 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
511621968 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
51365 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
51162 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5516115 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4282530 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6184553 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4820050 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-616073 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-485358 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18391 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
63352 usd
CY2022Q2 us-gaap Revenues
Revenues
1217 usd
CY2021Q2 us-gaap Revenues
Revenues
1144 usd
us-gaap Revenues
Revenues
5883 usd
us-gaap Revenues
Revenues
4182 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
2068 usd
us-gaap Cost Of Revenue
CostOfRevenue
214 usd
us-gaap Cost Of Revenue
CostOfRevenue
2068 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
1217 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
-924 usd
us-gaap Gross Profit
GrossProfit
5669 usd
us-gaap Gross Profit
GrossProfit
2114 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20934 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22146 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
79302 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74576 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
203408 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
199664 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
710788 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
471446 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
72509 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
5500 usd
us-gaap Professional Fees
ProfessionalFees
575541 usd
us-gaap Professional Fees
ProfessionalFees
52948 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
296851 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
227310 usd
us-gaap Operating Expenses
OperatingExpenses
1365631 usd
us-gaap Operating Expenses
OperatingExpenses
598970 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-295634 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-228234 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1359962 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-596856 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
1538 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
1400 usd
us-gaap Interest Expense
InterestExpense
4541 usd
us-gaap Interest Expense
InterestExpense
18939 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1538 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1400 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4541 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18939 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-297172 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-229634 usd
us-gaap Net Income Loss
NetIncomeLoss
-1364503 usd
us-gaap Net Income Loss
NetIncomeLoss
-615795 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
512867867 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
366469029 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
512028140 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
432475901 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
512867867 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
366469029 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
512028140 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
432475901 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-624019 usd
CY2022Q2 halb Common Stock Issued For Settlement Of3 A10 Debts Amount
CommonStockIssuedForSettlementOf3A10DebtsAmount
9466 usd
CY2022Q2 halb Shares Cancelled Amount
SharesCancelledAmount
0 usd
CY2022Q2 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
28152 usd
CY2022Q2 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
267500 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-297172 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-616073 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-342944 usd
CY2021Q2 halb Common Stock Issued For Settlement Of3 A10 Debts Amount
CommonStockIssuedForSettlementOf3A10DebtsAmount
18200 usd
CY2021Q2 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
217500 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-229634 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-336878 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-485358 usd
halb Common Stock Issued For Settlement Of3 A10 Debts Amount
CommonStockIssuedForSettlementOf3A10DebtsAmount
9466 usd
halb Shares Cancelled Amount
SharesCancelledAmount
0 usd
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
479322 usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
745000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1364503 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-616073 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-292776 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000 usd
halb Common Stock Issued For Settlement Of3 A10 Debts Amount
CommonStockIssuedForSettlementOf3A10DebtsAmount
58765 usd
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
20612 usd
halb Contributed Capital
ContributedCapital
482316 usd
us-gaap Net Income Loss
NetIncomeLoss
-615795 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-336878 usd
us-gaap Net Income Loss
NetIncomeLoss
-1364503 usd
us-gaap Net Income Loss
NetIncomeLoss
-615795 usd
us-gaap Depreciation
Depreciation
315 usd
us-gaap Depreciation
Depreciation
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
479322 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
20612 usd
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
16340 usd
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-14583 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
90803 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
69529 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4417 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3839 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-773306 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-536398 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3853 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3853 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
10000 usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
745000 usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
482315 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
745000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
642315 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-32159 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
105917 usd
CY2021Q3 us-gaap Cash
Cash
40321 usd
CY2020Q3 us-gaap Cash
Cash
2086 usd
CY2022Q2 us-gaap Cash
Cash
8162 usd
CY2021Q2 us-gaap Cash
Cash
108003 usd
us-gaap Interest Paid Net
InterestPaidNet
124 usd
us-gaap Interest Paid Net
InterestPaidNet
15100 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
halb Fair Value Of Common Stock Issued On Settlement Of Debts
FairValueOfCommonStockIssuedOnSettlementOfDebts
649059 usd
halb Fair Value Of Common Stock Issued On Settlement Of Debts
FairValueOfCommonStockIssuedOnSettlementOfDebts
6904338 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
3935000 usd
us-gaap Advertising Expense
AdvertisingExpense
53936 usd
us-gaap Advertising Expense
AdvertisingExpense
46624 usd
halb Research And Development Agreement Description
ResearchAndDevelopmentAgreementDescription
The Research Agreement, which terminates on November 30, 2022, calls for monthly payments of $50,000, not to exceed $1,371,782
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
710788 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
471446 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6184553 usd
CY2022Q2 halb Working Capital
WorkingCapital
-470892 usd
halb Legal Court Settlement Description
LegalCourtSettlementDescription
Order, including any obligation to issue the 486,850,070 shares … and …. to receive shares in any of the other Issuers is hereby extinguished. The 19,438,077 shares, which Halberd was obligated to issue SCI shall increase to 321,943,143, to reflect the corresponding decrease in its share price
us-gaap Forward Contract Indexed To Issuers Equity Shares
ForwardContractIndexedToIssuersEquityShares
486850070 shares
CY2022Q2 us-gaap Compensating Balance Amount
CompensatingBalanceAmount
30449 usd
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
86998604 shares
CY2022Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.00035
CY2022Q1 us-gaap Contractual Obligation
ContractualObligation
82231 usd
halb Issuance Of Aggregate Common Shares
IssuanceOfAggregateCommonShares
392732957 shares
CY2022Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
150000 usd
CY2021Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
150000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
4417 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
3839 usd
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
513650338 shares
CY2022Q1 halb Common Stock Issued In Satisfaction Of Judgments Payable
CommonStockIssuedInSatisfactionOfJudgmentsPayable
27044110 shares
CY2022Q1 halb Common Stock Issued In Satisfaction Of Judgments Payable Amount
CommonStockIssuedInSatisfactionOfJudgmentsPayableAmount
9466 usd
CY2022Q1 halb Common Stock Issued Satisfaction Judgments Payable Per Share
CommonStockIssuedSatisfactionJudgmentsPayablePerShare
0.00035
CY2022Q1 halb Common Stock Shares Cancelled
CommonStockSharesCancelled
25015740 shares
CY2022Q2 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
745000 usd
halb Common Stock Warrants
CommonStockWarrants
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 7 – Common Stock Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Warrants to purchase a total of 485,850,000 shares of common stock at a weighted average strike price of $0.01 were outstanding as of April 30, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Warrants Granted for Services</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 24, 2022, the Company issued warrants to purchase 1,000,000 shares, exercisable at $0.019 per share over a ten-year term, to an individual for services provided. The estimated fair value of the warrants using the Black-Scholes Pricing Model, based on a weighted average volatility rate of 239% and a weighted average call option value of $0.0188, was $18,768.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 24, 2022, the Company issued warrants to purchase 500,000 shares, exercisable at $0.019 per share over a ten-year term, to an individual for services provided. The estimated fair value of the warrants using the Black-Scholes Pricing Model, based on a weighted average volatility rate of 239% and a weighted average call option value of $0.0188, was $9,384.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 22, 2022, the Company issued warrants to purchase 750,000 shares, exercisable at $0.0196 per share over a ten-year term, to an individual for services provided. The estimated fair value of the warrants using the Black-Scholes Pricing Model, based on a weighted average volatility rate of 292% and a weighted average call option value of $0.0196, was $14,685.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 15, 2022, the Company issued warrants to purchase 10,000,000 shares, exercisable at $0.0206 per share over a ten-year term, to an individual for services provided. The estimated fair value of the warrants using the Black-Scholes Pricing Model, based on a weighted average volatility rate of 293% and a weighted average call option value of $0.0206, was $205,788.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 15, 2021, the Company issued warrants to purchase 1,000,000 shares, exercisable at $0.0175 per share over a ten-year term, to an individual for services provided. The estimated fair value of the warrants using the Black-Scholes Pricing Model, based on a weighted average volatility rate of 297% and a weighted average call option value of $0.0175, was $17,484.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2021, the Company issued warrants to purchase 10,000,000 shares, exercisable at $0.0188 per share over a ten-year term, to an individual for services provided. The estimated fair value of the warrants using the Black-Scholes Pricing Model, based on a weighted average volatility rate of 300% and a weighted average call option value of $0.0188, was $187,853.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2021, the Company issued warrants to purchase 1,000,000 shares, exercisable at $0.0188 per share over a ten-year term, to an individual for services provided. The estimated fair value of the warrants using the Black-Scholes Pricing Model, based on a weighted average volatility rate of 300% and a weighted average call option value of $0.0188, was $18,785.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2021, the Company issued warrants to purchase 350,000 shares, exercisable at $0.0188 per share over a ten-year term, to an individual for services provided. The estimated fair value of the warrants using the Black-Scholes Pricing Model, based on a weighted average volatility rate of 300% and a weighted average call option value of $0.0188, was $6,575.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Amended Warrants</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2021, the Company cancelled previously issued warrants to purchase 250,000 shares, exercisable at $0.0235 per share and issued new warrants to purchase 250,000 shares, exercisable at $0.0188 per share over a ten-year term, to an individual for services provided. The estimated fair value of the warrants using the Black-Scholes Pricing Model, based on a weighted average volatility rate of 300% and a weighted average call option value of $0.0188, was $4,696, which was not materially different than the value of the cancelled warrants.</p>
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
485850000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.01
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
826350 usd
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
640500 usd
CY2022Q2 halb Net Deferred Tax Assets Before Valuation Allowance
NetDeferredTaxAssetsBeforeValuationAllowance
826350 usd
CY2021Q3 halb Net Deferred Tax Assets Before Valuation Allowance
NetDeferredTaxAssetsBeforeValuationAllowance
640500 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
826350 usd
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
640500 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.21 pure
us-gaap Broadcasters License Agreement Commitments Description
BroadcastersLicenseAgreementCommitmentsDescription
The Company has received a binding funding commitment from Epidemiological Solutions Corporation, a charitable organization recently approved by the Internal Revenue Service and qualified under Internal Revenue Code section 501(c)(3), for $2,000,000 to fund the Company’s research and development endeavors. As of April 30, 2022, $889,782 had been paid on this commitment, beginning with the first payment of $21,782 on, or about, September 2, 2020, as presented as Contributed Capital within the Statement of Stockholders Equity (Deficit). The charitable organization is committed to monthly payments of $50,000 pursuant to its sponsored research agreement with Arizona State University.
halb Description Of Research Agreement
DescriptionOfResearchAgreement
The Research Agreement, which terminates on November 30, 2022, calls for monthly payments of $50,000, not to exceed $1,371,782.
CY2021Q3 us-gaap Advance Payments Netted Against Claim Receivable
AdvancePaymentsNettedAgainstClaimReceivable
521782 usd
CY2021Q3 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
850000 usd
CY2014Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
279447 usd
halb Balance Outstanding On Legal Settlement
BalanceOutstandingOnLegalSettlement
176485 usd
CY2022Q2 halb Balance Outstanding Amount Converted Into Common Stock Shares
BalanceOutstandingAmountConvertedIntoCommonStockShares
278690243 usd
us-gaap Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
0.00063
CY2014Q4 us-gaap Government Assistance Amount
GovernmentAssistanceAmount
2934889 usd
CY2016Q2 us-gaap Government Assistance Amount
GovernmentAssistanceAmount
2822209 usd
CY2016Q2 us-gaap Government Assistance Amount
GovernmentAssistanceAmount
112680 usd
CY2022Q2 us-gaap Compensating Balance Amount
CompensatingBalanceAmount
30449 usd
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
86998604 shares
CY2022Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.00035
CY2022Q2 halb Aggregate Market Value Of Judgments Payable In Common Stock
AggregateMarketValueOfJudgmentsPayableInCommonStock
6582399 usd
CY2021Q2 halb Aggregate Market Value Of Judgments Payable In Common Stock
AggregateMarketValueOfJudgmentsPayableInCommonStock
16876585 usd
CY2022Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.018
CY2021Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.039

Files In Submission

Name View Source Status
0001477932-22-006489-index-headers.html Edgar Link pending
0001477932-22-006489-index.html Edgar Link pending
0001477932-22-006489.txt Edgar Link pending
0001477932-22-006489-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
halb-20220430.xsd Edgar Link pending
halb_10q.htm Edgar Link pending
halb_ex311.htm Edgar Link pending
halb_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
halb-20220430_pre.xml Edgar Link unprocessable
halb-20220430_def.xml Edgar Link unprocessable
halb-20220430_lab.xml Edgar Link unprocessable
halb-20220430_cal.xml Edgar Link unprocessable
halb_10q_htm.xml Edgar Link completed